New Deal With Pharmaceuticals Firm to Help Hospital Treat Rare Diseases
Cincinnati Children’s has negotiated a deal with pharmaceuticals firm Shire Plc to develop drugs to treat rare diseases.
“We are very excited to partner with Shire in this capacity as we strive to change the outcome for children with rare and complex diseases,” said Dr. Margaret Hostetter, chief medical officer of Cincinnati Children’s and director of the research foundation. “Cincinnati Children’s full spectrum of research capabilities – basic, clinical and translational – coupled with Shire’s drug-development expertise makes for a very powerful partnership that we hope will have an impact on patients around the world.”
The Cincinnati Business Courier has the full story on the new deal at its website.